These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27583691)

  • 41. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
    Itonaga H; Taguchi J; Fukushima T; Tsushima H; Sato S; Ando K; Sawayama Y; Matsuo E; Yamasaki R; Onimaru Y; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Honda S; Miyazaki Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):607-15. PubMed ID: 23333533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
    Cook G; Clark RE; Crawley C; Mackinnon S; Russell N; Thomson K; Pearce RM; Towlson K; Marks DI
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.
    Sengsayadeth S; Savani BN; Blaise D; Malard F; Nagler A; Mohty M
    Haematologica; 2015 Jul; 100(7):859-69. PubMed ID: 26130513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T-cell receptor excision circle levels after allogeneic stem cell transplantation are predictive of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Uzunel M; Sairafi D; Remberger M; Mattsson J; Uhlin M
    Stem Cells Dev; 2014 Jul; 23(14):1559-67. PubMed ID: 24617310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravascular haemolysis secondary to Clostridium perfringens in a patient with acute myeloid leukaemia undergoing allogeneic stem cell transplantation.
    Renaudon-Smith E; Kaur M; Haroon A; Cavenagh J; Butler T
    Br J Haematol; 2014 Jun; 165(6):743. PubMed ID: 24446867
    [No Abstract]   [Full Text] [Related]  

  • 47. Allogeneic transplantation as therapy for acute myelogenous leukemia in the elderly.
    Schiller GJ
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):437-8. PubMed ID: 24487045
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia.
    Araki D; Othus M; Walter RB; Sandhu V; Sandmaier BM; Becker PS; Appelbaum FR; Estey EH
    Haematologica; 2015 Jul; 100(7):e254-6. PubMed ID: 25795719
    [No Abstract]   [Full Text] [Related]  

  • 49. Induction of late graft-versus-host disease in a patient post-allogeneic stem cell transplantation by progesterone in conjunction with donor lymphocyte infusion.
    Gesundheit B; Shapira MY; Maly A; Samuel S; Budowski E; Or R
    Leuk Res; 2008 Mar; 32(3):501-3. PubMed ID: 17727947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fatal skin and pulmonary infection caused by Hormographiella aspergillata in a leukaemic patient: case report and literature overview.
    Bojic M; Willinger B; Rath T; Tobudic S; Thalhammer F; Böhm A; Mitterbauer M; Schulenburg A; Wöhrer S; Kalhs P; Rabitsch W
    Mycoses; 2013 Nov; 56(6):687-9. PubMed ID: 23672484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation.
    Vehreschild JJ; Krüger K; Kurzai O; Wickenhauser C; Behringer K; Töx U; Cornely OA
    Mycoses; 2006; 49 Suppl 1():42-7. PubMed ID: 16961582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytogenetic patterns of relapse following allogeneic stem cell transplantation in morphologic complete remission in patients with acute myeloid leukemia.
    Rashidi A; Cashen AF
    Leuk Res; 2015 Jun; 39(6):553-4. PubMed ID: 25843488
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia.
    Tomonari A; Tojo A; Adachi D; Iseki T; Ooi J; Shirafuji N; Tani K; Asano S
    Ann Hematol; 2003 Jan; 82(1):37-40. PubMed ID: 12574963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia--recent progress].
    Okamoto S
    Nihon Rinsho; 2009 Oct; 67(10):1944-50. PubMed ID: 19860195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients.
    Muetherig A; Christopeit M; Müller LP; Grothe W; Weber T; Theurich S; Behre G
    Bone Marrow Transplant; 2007 Mar; 39(5):315-6. PubMed ID: 17311086
    [No Abstract]   [Full Text] [Related]  

  • 56. Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach.
    Lodewyck T; Cornelissen JJ
    Blood Rev; 2008 Nov; 22(6):293-302. PubMed ID: 18455284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
    Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G
    Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
    Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
    Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation.
    Bastos-Oreiro M; Perez-Corral A; Martínez-Laperche C; Bento L; Pascual C; Kwon M; Balsalobre P; Muñoz C; Buces E; Serrano D; Gayoso J; Buño I; Anguita J; Diéz-Martín JL
    Eur J Haematol; 2014 Sep; 93(3):239-46. PubMed ID: 24702162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.